Pregnancy-associated breast cancer

Acta Obstetricia et Gynecologica Scandinavica

Volumn 90, Issue 2, 2011, Pages 158-166

  Asgeirsson, Kristjan Skuli ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Breast; breast cancer; chemotherapy; pregnancy; surgery; survival

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; TAMOXIFEN; TRASTUZUMAB;

ANAMNESIS; AXILLA; BREAST BIOPSY; BREAST CANCER; BREAST RECONSTRUCTION; CANCER RADIOTHERAPY; CLINICAL EXAMINATION; CYTOLOGY; DELAYED DIAGNOSIS; FAMILY HISTORY; FEMALE; HISTOLOGY; HUMAN; LACTATION; MASTECTOMY; PATHOLOGY; PREGNANCY; PREGNANCY ASSOCIATED BREAST CANCER; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THERAPY DELAY; ULTRASOUND;

BREAST NEOPLASMS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 79951562215     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2010.01035.x     Document Type: Review

References (75)

1. White TT,. Carcinoma of the breast associated with pregnancy: report of fifty-six cases followed five years or more. Northwest Med. 1958; 57: 477-81.
2. Antonelli NM, Dotters DJ, Katz VL, Kuller JA,. Cancer in pregnancy: a review of the literature. Part I. Obstet Gynecol Surv. 1996; 51: 125-34.
3. Beadle BM, Woodward WA, Middleton LP, Tereffe W, Strom EA, Litton JK, et al,. The impact of pregnancy on breast cancer outcomes in women
4. Sondik EJ, Anderson JR, Curtin LR, et al,. Centers for Disease Control and Prevention. National Center for Health Statistics. Trends in pregnancies and pregnancy rates by outcome: Estimates for the United States, 1976-996. Series 21: 56; 5-7.
5. Sondik EJ,. Breast cancer trends. Incidence, mortality, and survival. Cancer. 1994; 74: 995-9. (Pubitemid 24231993)
6. Andersson TM-L, Johannsson ALV, Hsieh C-C, Cnattingius S, Lambe M,. Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol. 2009; 114: 568-72.
7. Ishida T, Yokoe T, Kasumi F, Sakamoto G, Makita M, Tominaga T, et al,. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res. 1992; 83: 1143-9. (Pubitemid 23009034)
8. Reed W, Sandstad B, Holm R, Nesland JM,. The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators. Int J Surg Pathol. 2003; 11: 65-74. (Pubitemid 36569927)
9. Bonnier P, Romain S, Dilhudy JM, Bonichon F, Julien JP, Charpin C, et al,. Influence of pregnancy on the outcome of breast cancer: a case-control study. Int J Cancer. 1997; 72: 720-7. (Pubitemid 27431510)
10. Petrek JA,. Pregnancy-associated breast cancer. Semin Surg Oncol. 1991; 7: 306-10.
11. Guinee VF, Olsson H, Moller T, Hess KR, Taylor SH, Fahey T, et al,. Effect of pregnancy on prognosis for young women with breast cancer. Lancet. 1994; 343: 1587-9. (Pubitemid 24194803)
12. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Burke B, Sutcliffe S, et al,. Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol. 1992; 166: 781-7.
13. Gemignani ML, Petrek JA,. Pregnancy-associated breast cancer: Diagnosis and treatment. Breast J. 2001; 6: 68-73.
14. Dunnwald LK, Rossing MA, Li CI,. Hormone receptor status, tumour characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007; 9: R6.
15. Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A,. Breast carcinoma in pregnant women: assessment of clinicopathological and immunohistohemical features. Cancer 2003; 98: 1055-60. (Pubitemid 37022108)
16. Merkel DE,. Pregnancy and breast cancer. Semin Surg Oncol. 1996; 12: 370-5. (Pubitemid 26300017)
17. Hoover HC Jr,. Breast cancer during pregnancy and lactation. Surg Clin North Am. 1990; 70: 1151-62.
18. Mathelin C, Annane K, Treisser A, Chennard MP, Tomasetton C, Bellocq JP, et al,. Pregnancy and post-partum breast cancer: a prospective study. Anticancer Res. 2008; 28: 2447-52.
19. Reed W, Hannisdal E, Skovlund E, Thoresen S, Lilleng P, Nesland JM,. Pregnancy and breast cancer: a population-based study. Virchows Arch. 2003; 443: 44-50. (Pubitemid 36920950)
20. Elledge RM, Ciocca DR, Langone G, McGuire WL,. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Cancer. 1993; 71: 2499-506. (Pubitemid 23100483)
21. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, et al,. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989; 244: 707-12. (Pubitemid 19147683)
22. Nettleton J, Long J, Kuban D, Wu R, Shaeffler J, El-Mahdi A,. Breast cancer during pregnancy: quantifying the risk of treatment delay. Obstet Gynecol. 1996; 87: 414-18. (Pubitemid 26075081)
23. Loibl S, Ring A, Von Minckwitz G, Lenhard M, Amant F, Weiss C, et al,. Breast cancer during pregnancy-A prospective and retrospective European registry (GBG-20/BIG02-03). J Clin Oncol. 2008; 26,15S: 22143.
24. Samphao S, Wheeler AJ, Rafferty E, Michaelson JS, Specht MC, Gadd MA, et al,. Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging. Am J Surg. 2009; 198: 538-43.
25. Johannsson O, Loman N, Borg A, Olsson H,. Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers. Lancet. 1998; 352: 1359-60. (Pubitemid 28510925)
26. Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, et al,. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer. 2005; 117: 988-91. (Pubitemid 41688574)
27. Navrazaglou I, Vrekoussis T, Kontostolis E, Dousias V, Zervoudis S, Stathopoulos EN, et al,. Breast cancer during pregnancy: A mini-review. Eur J Surg Oncol. 2008; 34: 837-43.
28. Ribeiro G, Jones DA, Jones M,. Carcinoma of the breast associated with pregnancy. Br J Surg. 1986; 73: 607-9. (Pubitemid 16039353)
29. Saber A, Dardik H, Ibrahim IM, Wolodiger F,. The milk rejection sign: a natural tumor marker. Am Surg. 1996; 62: 998-9. (Pubitemid 26394258)
30. Doyle S, Messiou C, Rutherford JM, Dineen RA,. Cancer presenting during pregnancy: radiological perspectives. Clin Radiol. 2009; 64: 857-71.
31. Bo YA, Hak HK, Woo KM, et al,. Pregnancy and lactation-associated breast cancer; mammographic and sonographic findings. J Ultrasound Med. 2003; 22: 491-7.
32. Novotny DB, Maygarden SJ, Shermer W, Frable WJ,. Fine needle aspiration of benign and malignant breast masses associated pregnancy. Acta Cytol. 1991; 35: 676-86.
33. Schackmuth EM, Harlow CL, Norton LW,. Milk fistula: a complication after core breast biopsy. Am J Roentgenol. 1993; 161: 961-2. (Pubitemid 23333152)
34. Sechopoulos I, Suryanarayanan S, Vedantham S, D'Orsi CJ, Karellas A,. Radiation dose to organs and tissues from mammography: Monte Carlo and phantom study. Radiology. 2007; 246: 434-43.
35. Behrman RH, Homer MJ, Yang WT, Whitman GJ,. Mammography and fetal dose. Radiology. 2007; 243: 605-6.
36. Shellock FG, Kanal E,. Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging. 1999; 10: 477-84. (Pubitemid 29463135)
37. Bishop HM, Blamey RW, Morris AH, Rose DH, Preston B, Lane J, et al,. Bone scanning: its lack of value in the follow up of patients with breast cancer. Br J Surg. 1979; 66: 752-4. (Pubitemid 10231666)
38. Palli D, Russo A, Saieva C, Ciatto S, Rosselli Del Turco M, Distante V, et al,. Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up. JAMA. 1999; 281: 1586. (Pubitemid 29211763)
39. Hubay CA, Barry FM, Marr CC,. Pregnancy and breast cancer. Surg Clin North Am. 1978; 58: 819-31. (Pubitemid 9020840)
40. Nugent P, O'Connell TX,. Breast cancer and pregnancy. Arch Surg. 1985; 120: 1221-4. (Pubitemid 16250740)
41. Barnovan Y, Wallack MK,. Management of the pregnant patient with carcinoma of the breast. Surg Gynecol Obstet. 1990; 171: 347-352. (Pubitemid 20383530)
42. NCCN Clinical Practice Guidelines in Oncology™. Breast Cancer V.2.2010.
43. Loibl S, von Minckwitz G, Gwyn K, Ellis P, Blohmer JU, Schlegelberger B, et al,. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer. 2006; 106: 237-46. (Pubitemid 43100430)
44. Khera SY, Kiluk JV, Hasson DM, Meade TL, Meyers MP, Dupont EL, et al,. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J. 2008; 14: 250-4. (Pubitemid 351678056)
45. Mondi MM, Cuenca RE, Ollila DW, Stewart JH 4th, Levine EA,. Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol. 2007; 14: 218-21. (Pubitemid 44954292)
46. Filippakis GM, Zografos G,. Contraindications of sentinel lymph node biopsy: are there any really? World J Surg Oncol. 2007; 5: 10.
47. Keleher A, Wendt R 3rd, Delpassand E, Stachowiak AM, Kuerer HM,. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J. 2004; 10: 492-495. (Pubitemid 39524981)
48. Russell JR, Stabin MG, Sparks RB, Watson E,. Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals. Health Phys. 1997; 73: 756-69. (Pubitemid 27444395)
49. Gentilini O, Cremonesi M, Toesca A, Colombo N, Peccatori F, Sironi R, et al,. Sentinel lymph node biopsy in pregnant patients with breast cancer. Eur J Nucl Med Mol Imaging. 2010; 37: 78-83.
50. Gentilini O, Cremonesi M, Trifiro G, Ferrari M, Baio SM, Caracciolo M, et al,. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004; 15: 1348-51. (Pubitemid 39295022)
51. Arceci RJ, Croop JM, Horwitz SB, Housman D,. The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci U S A. 1988; 85: 4350-4.
52. Smit JW, Huisman MT, van Tellingen O, Wiltshire HR, Schinkel AH,. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest. 1999; 104: 1441-7.
53. Ebert U, Loffler H, Kirch W,. Cytotoxic therapy and pregnancy. Pharmacol Ther. 1997; 74: 207-20. (Pubitemid 27340586)
54. Berry DL, Theriault RL, Holmes FA, Parisi VM, Booser DJ, Singletary SE, et al,. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol. 1999; 17: 855-61. (Pubitemid 29109315)
55. Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, et al,. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006; 107: 1219-26. (Pubitemid 44452769)
56. Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W, et al,. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and neonatal outcomes. J Clin Oncol. 2010; 28: 683-9.
57. Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA,. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol. 2005; 23: 4192-7. (Pubitemid 46211325)
58. Giacalone P-L, Laffargue F, Bénos P,. Chemotherapy for breast carcinoma during pregnancy. A French national survey. Cancer. 1999; 86: 2266-72. (Pubitemid 30010367)
59. Nicholson HO,. Cytotoxic drugs in pregnancy. J Obstet Gynaecol Br Commonw. 1968; 75: 307-12.
60. Mir O, Berveiller P, Goffinet F, Treluyer J-M, Serrau R, Goldwasser F, et al,. Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol. 2010; 21: 425-6.
61. Isaacs RJ, Hunter W, Clark K,. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy-case report and literature review. Gynecol Oncol. 2001; 80: 405-8. (Pubitemid 32207545)
62. Fanale MA, Uyei AR, Theriault RL, Adam K, Thompson RA,. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin Breast Cancer. 2005; 6: 354-6. (Pubitemid 41715698)
63. Waterson AM, Graham J,. Effect of adjuvant trastuzumab on pregnancy. J Clin Oncol. 2006; 24: 321-2. (Pubitemid 46622061)
64. Watson WJ,. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet Gynecol. 2005; 105: 642-3. (Pubitemid 40271236)
65. Sekar R, Stone PR,. Trastuzumab use for metastatic breast cancer in pregnancy. Obstet Gynecol. 2007; 110: 507-10. (Pubitemid 47417745)
66. Bader AA, Schlembach D, Tamussino KF, Pristauz G, Petru E,. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol. 2007; 8: 79-81. (Pubitemid 46043032)
67. Pant S, Landon MB, Blumenfeld M, Farrar W, Shapiro CL,. Treatment of breast cancer with trastuzumab during pregnancy. J Clin Oncol. 2008; 26: 1567-69.
68. Witzel ID, Muller V, Harps E, Janicke F, Dewit M,. Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol. 2007; 19: 191-5.
69. Shrim A, Garcia-Bournissen F, Maxwell C, Farine D, Koren G,. Favorable pregnancy outcome following trastuzumab use during pregnancy-case report and updated literature review. Reprod Toxicol. 2007; 23: 611-13. (Pubitemid 46754746)
70. Durodola J,. Administration of cyclophosphamide during late pregnancy and early lactation: a case report. J Natl Med Assoc. 1979; 71: 165-6. (Pubitemid 9138057)
71. Higgins S, Haffty BG,. Pregnancy and lactation after breast-conserving therapy for early stage breast cancer. Cancer. 1994; 73: 2175-80. (Pubitemid 24107973)
72. Moran MS, Colasanto JM, Haffty BG, Wilson LD, Lund MW, Higgins SA,. Effects of breast-conserving therapy on lactation after pregnancy. Cancer J. 2005; 11: 399-403. (Pubitemid 41725731)
73. Grotmol T, Weiderpass E, Tretli S,. Conditions in utero and cancer risk. Eur J Epidemiol. 2006; 21: 561-70.
74. Tretli S, Kvalheim G, Thoresen S, Host H,. Survival of breast cancer patients diagnosed during pregnancy or lactation. Br J Cancer. 1988; 58: 382-4.
75. Ibrahim EM, Ezzat AA, Baloush A, Hussain ZH, Mohammed GH,. Pregnancy-associated breast cancer: a case-control study in a young population with a high fertility rate. Med Oncol. 2000; 17: 293-300.